RBC Life Science and Technology Fund Series D (RBF1030)

RBC Life Science and Technology Fund Series D (RBF1030 $65.84)
- $65.84 Fwd P/E: 23.7X
- View RBF1030 Profile
- View Questions on RBF1030

{tplLang.businessdescription | toLang tLang}

{ profileData.description }

{tplLang.details | toLang tLang}

{tplLang.ceo | toLang tLang}

{profileData.profile.details.ceo}

{tplLang.employees | toLang tLang}

{profileData.profile.details.employees | numeraljs '0,0'}

{tplLang.issuetype | toLang tLang}

{profileData.profile.details.issuetype | asIssueType}

{tplLang.industryclassifications | toLang tLang}

{tplLang.sector | toLang tLang}

{profileData.profile.classification.sector}

{tplLang.industry | toLang tLang}

{profileData.profile.classification.industry}

{tplLang.toolname| toLang tLang}

There is no {tplLang.toolname| toLang tLang} currently available for {data.symbolstring}.

BMO Nasdaq 100 Equity Hedged To CAD Index ETF (ZQQ $160.40)
- $160.40 Fwd P/E: 72.82X Cap: $2.38B
- View ZQQ Profile
- View Questions on ZQQ
RBC Life Science and Technology Fund Series D (RBF1030 $65.84)
- $65.84 Fwd P/E: 23.7X
- View RBF1030 Profile
- View Questions on RBF1030

Q: Over the long run these two technology ETFs show comparable returns. However while ZQQ has significantly outperformed RBF1030 over the past year, the trend has reversed over the last month. RBF 1030 has a higher healthcare component than ZQQ and recent healthcare news (diabetes, weight loss drugs) seem to be driving it forward while stumbling tech shares recently are holding back this component. Given the big run up in technology over the past year, do you think RBF1030 with its higher healthcare component might be safer or provide better performance over the next year or so.

Read Answer Asked by Ken on August 14, 2023

Royal Bank of Canada (RY $182.78)
- $182.78 Fwd P/E: 19.69X Cap: $256.73B
- View RY Profile
- View Questions on RY
BCE Inc. (BCE $32.83)
- $32.83 Fwd P/E: 77.38X Cap: $29.64B
- View BCE Profile
- View Questions on BCE
Enbridge Inc. (ENB $61.37)
- $61.37 Fwd P/E: 22.88X Cap: $134.89B
- View ENB Profile
- View Questions on ENB
- View Reports on ENB
Manulife Financial Corporation (MFC $41.86)
- $41.86 Fwd P/E: 15.96X Cap: $72.87B
- View MFC Profile
- View Questions on MFC
Loblaw Companies Limited (L $219.26)
- $219.26 Fwd P/E: 30.67X Cap: $66.63B
- View L Profile
- View Questions on L
Fortis Inc. (FTS $65.76)
- $65.76 Fwd P/E: 19.59X Cap: $32.52B
- View FTS Profile
- View Questions on FTS
Emera Incorporated (EMA $63.09)
- $63.09 Fwd P/E: 21.25X Cap: $18.67B
- View EMA Profile
- View Questions on EMA
Chartwell Retirement Residences (CSH.UN $17.96)
- $17.96 Fwd P/E: 85.38X Cap: $5.07B
- View CSH.UN Profile
- View Questions on CSH.UN
- View Reports on CSH.UN
Open Text Corporation (OTEX $39.54)
- $39.54 Fwd P/E: 11.66X Cap: $10.38B
- View OTEX Profile
- View Questions on OTEX
RBC Life Science and Technology Fund Series D (RBF1030 $65.84)
- $65.84 Fwd P/E: 23.7X
- View RBF1030 Profile
- View Questions on RBF1030
Brookfield Asset Management Inc Class A Limited (BAM $60.71)
- $60.71 Fwd P/E: 43.81X Cap: $97.97B
- View BAM Profile
- View Questions on BAM
Brookfield Renewable Partners L.P. Limited Partnership Units (BEP $27.34)
- $27.34 Cap: $17.90B
- View BEP Profile
- View Questions on BEP

Q: Good day,
I have built my daughter's RRSP with your wise direction. She is up 15 to 25% on BAM;EMA;FTS;L;OTEX;RY; BEP and RBF 1030.(My choice) Wonderful. Thank you. We are down in descending order on ENB;CSH;BCE and MFC.

Overweight in Utilities and Financials but okay with that.

Would you add to the latter group? Add any new ones.

Looking forward to Peter on BBN Tuesday.

Long term 25 years+. Many thanks!

Read Answer Asked by Paul on November 16, 2020

Royal Bank of Canada (RY $182.78)
- $182.78 Fwd P/E: 19.69X Cap: $256.73B
- View RY Profile
- View Questions on RY
BCE Inc. (BCE $32.83)
- $32.83 Fwd P/E: 77.38X Cap: $29.64B
- View BCE Profile
- View Questions on BCE
Enbridge Inc. (ENB $61.37)
- $61.37 Fwd P/E: 22.88X Cap: $134.89B
- View ENB Profile
- View Questions on ENB
- View Reports on ENB
Manulife Financial Corporation (MFC $41.86)
- $41.86 Fwd P/E: 15.96X Cap: $72.87B
- View MFC Profile
- View Questions on MFC
Loblaw Companies Limited (L $219.26)
- $219.26 Fwd P/E: 30.67X Cap: $66.63B
- View L Profile
- View Questions on L
George Weston Limited (WN $263.83)
- $263.83 Fwd P/E: 29.97X Cap: $34.17B
- View WN Profile
- View Questions on WN
Fortis Inc. (FTS $65.76)
- $65.76 Fwd P/E: 19.59X Cap: $32.52B
- View FTS Profile
- View Questions on FTS
Brookfield Renewable Partners L.P. (BEP.UN $37.42)
- $37.42 Cap: $24.56B
- View BEP.UN Profile
- View Questions on BEP.UN
- View Reports on BEP.UN
Emera Incorporated (EMA $63.09)
- $63.09 Fwd P/E: 21.25X Cap: $18.67B
- View EMA Profile
- View Questions on EMA
Open Text Corporation (OTEX $39.54)
- $39.54 Fwd P/E: 11.66X Cap: $10.38B
- View OTEX Profile
- View Questions on OTEX
RBC Life Science and Technology Fund Series D (RBF1030 $65.84)
- $65.84 Fwd P/E: 23.7X
- View RBF1030 Profile
- View Questions on RBF1030

Q: Hi,
I have approx 10% weight in these in a long term RRSP following your porfolios(Only 1% WN as spin off)
I have about $!0,000 to add. What are your thoughts?
Add to a few laggards or add new?

Read Answer Asked by Paul on March 08, 2019